These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 30301594)

  • 21. Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial.
    Lind M; Polonsky W; Hirsch IB; Heise T; Bolinder J; Dahlqvist S; Schwarz E; Ólafsdóttir AF; Frid A; Wedel H; Ahlén E; Nyström T; Hellman J
    JAMA; 2017 Jan; 317(4):379-387. PubMed ID: 28118454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prolonged nocturnal hypoglycemia is common during 12 months of continuous glucose monitoring in children and adults with type 1 diabetes.
    Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group
    Diabetes Care; 2010 May; 33(5):1004-8. PubMed ID: 20200306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial.
    Heinemann L; Freckmann G; Ehrmann D; Faber-Heinemann G; Guerra S; Waldenmaier D; Hermanns N
    Lancet; 2018 Apr; 391(10128):1367-1377. PubMed ID: 29459019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomised controlled study of high intensity exercise as a dishabituating stimulus to improve hypoglycaemia awareness in people with type 1 diabetes: a proof-of-concept study.
    Farrell CM; McNeilly AD; Fournier P; Jones T; Hapca SM; West D; McCrimmon RJ
    Diabetologia; 2020 Apr; 63(4):853-863. PubMed ID: 31942669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Retrospective analysis of the incidence of severe hypoglycemia in 458 type 1 diabetic patients].
    Bali C; Gurdet C; Irsigler K
    Acta Med Austriaca; 1997; 24(5):165-9. PubMed ID: 9480616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of pre-transplant psychosocial burden in an integrated national islet transplant program.
    Liew AY; Holmes-Truscott E; Flatt AJ; Bennett D; Crookston R; Pimkova M; Birtles L; Casey J; Pernet A; Wood RC; Choudhary P; Forbes S; Rutter MK; Rosenthal M; Johnson P; Shaw JA; Speight J
    Islets; 2020 Mar; 12(2):21-31. PubMed ID: 32815765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of real-time continuous glucose monitoring in type 1 diabetes: a meta-analysis of randomized controlled trials.
    Dicembrini I; Cosentino C; Monami M; Mannucci E; Pala L
    Acta Diabetol; 2021 Apr; 58(4):401-410. PubMed ID: 32789691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of continuous glucose monitor-recorded nocturnal hypoglycaemia on quality of life and mood during daily life in type 1 diabetes.
    Henriksen MM; Andersen HU; Thorsteinsson B; Pedersen-Bjergaard U
    Diabetologia; 2021 Apr; 64(4):903-913. PubMed ID: 33443591
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validating and Establishing a Diagnostic Threshold for the Hypoglycemia Awareness Questionnaire Impaired Awareness Subscale.
    Matus A; Flatt AJ; Peleckis AJ; Dalton-Bakes C; Riegel B; Rickels MR
    Endocr Pract; 2023 Oct; 29(10):762-769. PubMed ID: 37611750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Real-world patient-reported rates of non-severe hypoglycaemic events in Germany.
    Kulzer B; Seitz L; Kern W
    Exp Clin Endocrinol Diabetes; 2014 Mar; 122(3):167-72. PubMed ID: 24643694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What are the quality of life-related benefits and losses associated with real-time continuous glucose monitoring? A survey of current users.
    Polonsky WH; Hessler D
    Diabetes Technol Ther; 2013 Apr; 15(4):295-301. PubMed ID: 23427866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of continuous glucose monitoring system in the management of severe hypoglycemia.
    Ryan EA; Germsheid J
    Diabetes Technol Ther; 2009 Oct; 11(10):635-9. PubMed ID: 19821755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical Trial.
    Pratley RE; Kanapka LG; Rickels MR; Ahmann A; Aleppo G; Beck R; Bhargava A; Bode BW; Carlson A; Chaytor NS; Fox DS; Goland R; Hirsch IB; Kruger D; Kudva YC; Levy C; McGill JB; Peters A; Philipson L; Philis-Tsimikas A; Pop-Busui R; Shah VN; Thompson M; Vendrame F; Verdejo A; Weinstock RS; Young L; Miller KM;
    JAMA; 2020 Jun; 323(23):2397-2406. PubMed ID: 32543682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessing impaired hypoglycemia awareness in type 1 diabetes: agreement of self-report but not of field study data with the autonomic symptom threshold during experimental hypoglycemia.
    Janssen MM; Snoek FJ; Heine RJ
    Diabetes Care; 2000 Apr; 23(4):529-32. PubMed ID: 10857947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterizing Glycemic Control and Sleep in Adults with Long-Standing Type 1 Diabetes and Hypoglycemia Unawareness Initiating Hybrid Closed Loop Insulin Delivery.
    Malone SK; Peleckis AJ; Grunin L; Yu G; Jang S; Weimer J; Lee I; Rickels MR; Goel N
    J Diabetes Res; 2021; 2021():6611064. PubMed ID: 33628834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Islet Transplantation Provides Superior Glycemic Control With Less Hypoglycemia Compared With Continuous Subcutaneous Insulin Infusion or Multiple Daily Insulin Injections.
    Holmes-Walker DJ; Gunton JE; Hawthorne W; Payk M; Anderson P; Donath S; Loudovaris T; Ward GM; Kay TW; OʼConnell PJ
    Transplantation; 2017 Jun; 101(6):1268-1275. PubMed ID: 27490410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glucose and Counterregulatory Responses to Exercise in Adults With Type 1 Diabetes and Impaired Awareness of Hypoglycemia Using Closed-Loop Insulin Delivery: A Randomized Crossover Study.
    Lee MH; Vogrin S; Paldus B; Jayawardene D; Jones HM; McAuley SA; Obeyesekere V; Gooley J; La Gerche A; MacIsaac RJ; Sundararajan V; Jenkins AJ; Ward GM; O'Neal DN
    Diabetes Care; 2020 Feb; 43(2):480-483. PubMed ID: 31796571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frequency of symptomatic and asymptomatic hypoglycaemia in Type 1 diabetes: effect of impaired awareness of hypoglycaemia.
    Schopman JE; Geddes J; Frier BM
    Diabet Med; 2011 Mar; 28(3):352-5. PubMed ID: 21309845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Self-reported non-severe hypoglycaemic events in Europe.
    Östenson CG; Geelhoed-Duijvestijn P; Lahtela J; Weitgasser R; Markert Jensen M; Pedersen-Bjergaard U
    Diabet Med; 2014 Jan; 31(1):92-101. PubMed ID: 23796113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of a Smartphone Application to Reduce Hypoglycemia in Type 1 Diabetes: A Pilot Study.
    Feuerstein-Simon C; Bzdick S; Padmanabhuni A; Bains P; Roe C; Weinstock RS
    J Diabetes Sci Technol; 2018 Nov; 12(6):1192-1199. PubMed ID: 29291641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.